Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Iron chelates bind nitric oxide and decrease mortality in an experimental model of septic shock

W M Kazmierski1, G Wolberg, J G Wilson

  • 1Division of Organic Chemistry, Burroughs Wellcome, Research Triangle Park, NC 27709, USA.

Proceedings of the National Academy of Sciences of the United States of America
|August 20, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Spina Bifida Successfully Treated by Ligature and Puncture.

Atlanta medical and surgical journal·2022
Same author

Use of a novel oleaginous microorganism as a potential source of lipids for weanling pigs<sup></sup>.

Translational animal science·2020
Same author

A case of ANCA-associated vasculitis presenting de novo in pregnancy, successfully treated with rituximab.

Obstetric medicine·2020
Same author

Genome-wide meta-analysis of variant-by-diuretic interactions as modulators of lipid traits in persons of European and African ancestry.

The pharmacogenomics journal·2019
Same author

Report of Obstetric Cases Occurring in Hospital Practice.

Glasgow medical journal·2018
Same author

Two Cases of Concealed Accidental Hæmorrhage at the Full Term of Utero-Gestation.

Glasgow medical journal·2018

Iron chelators ferrioxamine B and DTPA protect against septic shock. The iron-free ligand H4DFB+ was more effective, suggesting NO scavenging and redox catalysis are key mechanisms for novel drug development.

Area of Science:

  • Biochemistry
  • Pharmacology
  • Medicinal Chemistry

Background:

  • Septic shock is a life-threatening condition often exacerbated by dysregulated nitric oxide (NO) production.
  • Iron chelators are being investigated for their therapeutic potential in various diseases, including sepsis.

Purpose of the Study:

  • To evaluate the efficacy of ferrioxamine B [FeIII(HDFB)+] and diethylenetri-aminepentaacetic acid [FeIII(DTPA)2-] in protecting against septic shock.
  • To investigate the underlying mechanisms of protection, focusing on NO scavenging and redox catalysis.

Main Methods:

  • Mice were subjected to septic shock induced by Corynebacterium parvum and lipopolysaccharide.
  • Treatment efficacy was assessed using iron complexes and iron-free ligands.
  • Electrochemical studies were performed to analyze the interaction of complexes with NO.

Related Experiment Videos

Main Results:

  • Both FeIII(DTPA)2- and FeIII(HDFB)+ demonstrated protective effects against septic shock.
  • The iron-free ligand H4DFB+ showed significantly greater efficacy than DTPA.
  • FeIII(DTPA)2- binds NO, while FeIII(HDFB)+ acts as an electrocatalyst for NO reduction to N2O.

Conclusions:

  • Septic shock protection is mediated by NO scavenging and redox catalysis.
  • Novel drugs targeting septic shock can be designed based on transition metal-mediated small molecule activation.
  • Siderophore chemistry provides a foundation for developing new therapeutic agents.